Asclera is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Merz North America, Inc. The primary component is Polidocanol.
| Product ID | 46783-121_1781730d-b81e-4e88-8218-b07b854e03cb |
| NDC | 46783-121 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Asclera |
| Generic Name | Polidocanol |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2010-06-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021201 |
| Labeler Name | Merz North America, Inc |
| Substance Name | POLIDOCANOL |
| Active Ingredient Strength | 0 g/mL |
| Pharm Classes | Sclerosing Agent [EPC],Sclerosing Activity [MoA],Vascular Sclerosing Activity [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2010-06-01 |
| Marketing End Date | 2022-08-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021201 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2010-06-01 |
| Ingredient | Strength |
|---|---|
| POLIDOCANOL | .005 g/mL |
| SPL SET ID: | 90550274-6605-44de-8c25-c5591080270f |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 46783-121 | Asclera | POLIDOCANOL |
| 46783-221 | Asclera | POLIDOCANOL |
| 67850-140 | Asclera | POLIDOCANOL |
| 67850-141 | Asclera | POLIDOCANOL |
| 60635-107 | Varithena | polidocanol |
| 60635-111 | Varithena | polidocanol |
| 60635-118 | Varithena | polidocanol |
| 60635-123 | Varithena | polidocanol |
| 60635-133 | Varithena | polidocanol |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ASCLERA 90035122 not registered Live/Pending |
Chemische Fabrik Kreussler & Co. GmbH 2020-07-03 |
![]() ASCLERA 77840002 3842974 Dead/Cancelled |
Chemische Fabrik Kreussler & Co. GmbH 2009-10-02 |